Knocking down Bcl2l10 downregulated IDH1 and SDHD and led to the accumulation of oncometabolites, such as succinate and isocitrate, and therefore led to the promotion and progression of ovarian cancer [52]. The gene discussed is IDH1; the disease is ovarian carcinoma.